EuroPCR

PCR is a European organization dedicated to education and information in the field of interventional cardiology and minimally invasive transcatheter procedures. Its activities cover a large spectrum, from the organization of annual courses in Europe, Asia, the Middle East and Africa, to editing a scientific journal, publishing textbooks as well as providing training seminars on thematic subjects. For more information, visit https://www.pcronline.com/Courses/EuroPCR.

TAVR or SAVR? ChatGPT could help cardiologists decide
Researchers asked ChatGPT to make treatment decisions for patients with severe aortic stenosis, comparing its answers to the recommendations of a full heart team.
Cardiologists may want to rethink how they track prosthesis-patient mismatch after TAVR
Researchers evaluated two techniques for predicting PPM after TAVR, comparing them to how cardiologists typically check for PPM in day-to-day practice.
EuroPCR 2023: Late-breaking research examines the latest in TEER, TAVR and PCI outcomes
Catch up on key late-breaking research from Abbott, Edwards Lifesciences and Philips presented at the four-day meeting in Paris.
Redo TAVR appears feasible for most patients with supra-annular, self-expanding Evolut valves
Researchers evaluated data from more than 200 patients who underwent redo TAVR, noting that women and patients with a higher BMI faced a higher risk of coronary flow compromise.
New self-expanding TAVR valve shows promise
It is still early for this new-look TAVR valve, but initial findings out of China include a procedural success rate of 100% and no deaths, disabling strokes or myocardial infarctions after 30 days. Read a full analysis from the team using the device.

EuroPCR: SOURCE Registry one-year mortality rates inform TAVI operators

Martyn Thomas, MD, director of cardiothoracic services, Guys and St. Thomas' NHS Foundation Trust in London, reported Tuesday on the one-year mortality rates with transcatheter heart valve implantations with the Sapien valve (Edwards Lifesciences) using either a transfemoral or transapical approach, based on results of 1,038 high-risk patients assessed in the SOURCE Registry at EuroPCR in Paris. Slides

May 27, 2010

EuroPCR: Resolute trends positively vs. Xience in all-comers trial

Medtronics Resolute zotarolimus-eluting stent was found to be as safe and effective as Abbott Vasculars Xience V everolimus-eluting stent in a predominantly off-label population, based on the results of the RESOLUTE all-comers trial, presented Tuesday by Patrick W. Serruys MD, PhD, at EuroPCR in Paris. Slides

May 27, 2010

EuroPCR: Pre-PCI hypothermia for STEMIs reduces infarct size

Inducing hypothermia by a combo infusion of cold saline and use of an endovascular cooling catheter is an effective adjuctive therapy for acute MI patients, according to a study presented Thursday by researchers from Lund University Hospital in Lund, Sweden, at EuroPCR in Paris.

May 26, 2010

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

EuroPCR

TAVR or SAVR? ChatGPT could help cardiologists decide

Cardiologists may want to rethink how they track prosthesis-patient mismatch after TAVR

EuroPCR 2023: Late-breaking research examines the latest in TEER, TAVR and PCI outcomes

Redo TAVR appears feasible for most patients with supra-annular, self-expanding Evolut valves

New self-expanding TAVR valve shows promise

Around the web